Literature DB >> 3978383

Cholecystectomy in the elderly: a prospective study.

P W Houghton, L R Jenkinson, L A Donaldson.   

Abstract

The mortality and morbidity of 151 elderly patients (greater than 64 years of age) undergoing biliary surgery for benign disease were prospectively studied. The overall mortality was 3.3 per cent. This comprised a 0.77 per cent mortality in the elective group and a 19 per cent mortality in the emergency group. In spite of 77 per cent of the emergency group having a gangrenous gallbladder, a complication difficult to predict preoperatively, the majority of deaths were from cardiovascular disease. The overall incidence of common bile duct exploration was 36 per cent, which was similar in the elective and emergency groups. A comparison between the old (65-74 years) and the aged (over 74 years of age) revealed twice the number of emergency cases in the aged. Considering elective biliary surgery, there was no difference between the mortality, morbidity, or common bile duct exploration rate comparing the old with the aged. This suggests that elective biliary surgery is safe even in the aged.

Entities:  

Mesh:

Year:  1985        PMID: 3978383     DOI: 10.1002/bjs.1800720327

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  37 in total

1.  Recent results of elective open cholecystectomy in a North American and a European center. Comparison of complications and risk factors.

Authors:  P A Clavien; J R Sanabria; G Mentha; F Borst; L Buhler; B Roche; R Cywes; R Tibshirani; A Rohner; S M Strasberg
Journal:  Ann Surg       Date:  1992-12       Impact factor: 12.969

2.  The operative risk factors of cholelithiasis in the elderly.

Authors:  N Shinagawa; K Mashita; J Yura
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

3.  Percutaneous cholecystostomy as an alternative to cholecystectomy in high risk patients with biliary sepsis: a district general hospital experience.

Authors:  W Al-Jundi; T Cannon; R Antakia; U Anoop; R Balamurugan; N Everitt; K Ravi
Journal:  Ann R Coll Surg Engl       Date:  2012-03       Impact factor: 1.891

4.  Ultrasound guided percutaneous cholecystostomy in high-risk patients for surgical intervention.

Authors:  Huseyin Bakkaloglu; Hakan Yanar; Recep Guloglu; Korhan Taviloglu; Fatih Tunca; Murat Aksoy; Cemalettin Ertekin; Arzu Poyanli
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

5.  Usefulness of single and repetitive percutaneous transhepatic gallbladder aspiration for the treatment of acute cholecystitis.

Authors:  Kunihiko Tsutsui; Naohito Uchida; Shuko Hirabayashi; Hideki Kamada; Masahiro Ono; Mutsumi Ogawa; Toru Ezaki; Hiroki Fukuma; Hideki Kobara; Yuichi Aritomo; Tsutomu Masaki; Toshiaki Nakatsu; Shigeki Kuriyama
Journal:  J Gastroenterol       Date:  2007-07-25       Impact factor: 7.527

6.  Clinical outcomes of a percutaneous cholecystostomy for acute cholecystitis: a multicentre analysis.

Authors:  Pandanaboyana Sanjay; Devender Mittapalli; Aseel Marioud; Richard D White; Rishi Ram; Afshin Alijani
Journal:  HPB (Oxford)       Date:  2012-11-19       Impact factor: 3.647

7.  Systematic review of cholecystostomy as a treatment option in acute cholecystitis.

Authors:  Anders Winbladh; Per Gullstrand; Joar Svanvik; Per Sandström
Journal:  HPB (Oxford)       Date:  2009-05       Impact factor: 3.647

8.  Surgery in a geriatric population.

Authors:  A P Barlow; Z Zarifa; R G Shillito; M K Crumplin; E Edwards; J M McCarthy
Journal:  Ann R Coll Surg Engl       Date:  1989-03       Impact factor: 1.891

9.  Percutaneous cholecystostomy is safe and effective option for acute calculous cholecystitis in select group of high-risk patients.

Authors:  M Bala; I Mizrahi; H Mazeh; J Yuval; A Eid; G Almogy
Journal:  Eur J Trauma Emerg Surg       Date:  2015-11-26       Impact factor: 3.693

10.  Percutaneous cholecystolithotomy: is gall stone recurrence inevitable?

Authors:  J J Donald; S Cheslyn-Curtis; A R Gillams; R C Russell; W R Lees
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.